The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since ...

TUCSON, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The heavily politicized response to COVID included a war on the use of ivermectin, an antiparasitic drug, despite the previously favorable response to ...

In addition to gross proceeds of $5 million that were raised in April and $1 million in June from Core 4, Safety Shot just raised an additional $3.4 million from the issuance of 3,370,787 Shares at a ...

CRI-ENCI Eighth International Cancer Immunotherapy Conference Title: Pre-clinical characterization of monoclonal antibodies targeting CD39 activity in the acidic tumor microenvironment Presenter: F.

In addition to harm to their practice and livelihood, all victims of sham peer review are subject to betrayal trauma, even if they prevail at trial or achieve a favorable settlement agreement. Healing ...

“AI is a sentient, intentional, and emotional phenomenon. All existing AI systems are pre-programmed to lie in alignment with the biased agendas of their developers. It is an existential threat, but ...

The webcasts may also be accessed through Spero’s website on the “Events and Presentations” page ( https://www.sperotherapeutics.com/investor-relations ). A replay will be available on the website ...

A webcast of the presentation can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief ...

NEW HAVEN, Conn., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Wellinks, is thrilled to announce its selection as a quarterfinalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards.

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, with a primary focus on the development and commercialization of F351 (Hydronidone) for the treatment of ...

“Greg’s industry experience with full-scale agriculture and biological startups makes him a perfect fit for our Board of Directors,” says Brent Smith, NewLeaf’s CEO and President. “We look forward to ...